Varex reports record Q3 revenue of $232M, up 8% YoY; non-GAAP EPS $0.37

Varex Imaging Corp

2023-Q3 EPS reported $0.40 revenue$666,000,000

Revenue $232M (record), up 8% YoY; Medical segment $175M (+5%), Industrial $57M (+20%).
GAAP EPS $0.21/diluted; non-GAAP EPS $0.37/diluted; non-GAAP gross margin 34% (above expectations).
Cash flow from operations $38M; cash & equivalents up $30M sequentially to $152M.
Q4 FY23 guidance: revenue $220M-$240M, non-GAAP EPS $0.20-$0.40 per diluted share.
CEO cites continued strength in Industrial segment and improved inventory management.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Varex Imaging Corp reported third quarter of fiscal year 2023 results: revenue $232 million, EPS $0.21 per diluted share. Guidance reaffirmed.

Period: third quarter of fiscal year 2023
Revenue: $232 million
EPS: $0.21 per diluted share
Guidance: reaffirmed
Result: preliminary results

Exact text from the filing

August 1, 2023 – Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the third quarter of fiscal year 2023. 3QFY23 Summary • Revenues $232 million • GAAP gross margin 33% | Non-GAAP gross margin* 34% • GAAP operating margin 10% | Non-GAAP operating margin* 13% • GAAP net earnings $0.21 per diluted share | Non-GAAP net

View on SEC.gov

Browse all earnings releases →

Varex Imaging Corp filing history →

Source: SEC EDGAR

accession 0001681622-23-000063

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.